SCHEMBL4791802

SCHEMBL4791802

COc1ccc(Cn2c(=O)c([N+](=O)[O-])c(C=Cc3cnn(Cc4ccccc4C(F)(F)F)c3)n(Cc3ccoc3)c2=O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPBWR1 P48145 1/20 0.40
MAPT P10636 3/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPK1 P28482 1/20 0.37
ADORA2A P29274 2/20 0.35
ADORA2B P29275 2/20 0.35
ADORA1 P30542 2/20 0.35
CMA1 P23946 2/20 0.34
SCD5 Q86SK9 1/20 0.33
ADORA3 P0DMS8 1/20 0.32
KLKB1 P03952 3/20 0.31
GABRA5 P31644 1/20 0.31
TAS2R8 Q9NYW2 1/20 0.31
P2RX7 Q99572 1/20 0.31
POLB P06746 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
MEN1 O00255 1/20 0.31
USP2 O75604 1/20 0.31
APEX1 P27695 1/20 0.31
RECQL P46063 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4791799 1.00 NPBWR1 (0.40) NPBWR1MAPTALDH1A1MAPK1ADORA2A
SCHEMBL4762462 0.94 NPBWR1 (0.44) NPBWR1MAPTALDH1A1MAPK1ADORA2A
SCHEMBL4762538 0.94 NPBWR1 (0.44) NPBWR1MAPTALDH1A1MAPK1ADORA2A
SCHEMBL4767375 0.93 ADORA2B (0.38) ALDH1A1MAPK1ADORA2AADORA2BADORA1
SCHEMBL4767385 0.93 ADORA2B (0.38) ALDH1A1MAPK1ADORA2AADORA2BADORA1
SCHEMBL4794079 0.92 MAPT (0.38) MAPTALDH1A1MAPK1ADORA2AADORA2B
SCHEMBL4794085 0.92 MAPT (0.38) MAPTALDH1A1MAPK1ADORA2AADORA2B
SCHEMBL4763642 0.90 ADORA2A (0.35) ALDH1A1MAPK1ADORA2AADORA2BADORA1
SCHEMBL4763634 0.90 ADORA2A (0.35) ALDH1A1MAPK1ADORA2AADORA2BADORA1
SCHEMBL4769234 0.90 NPBWR1 (0.41) NPBWR1MAPTALDH1A1MAPK1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed